open access
Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer — a pilot study
open access
Abstract
higher (HR = 0.503, 95% CI: 0.129–1.137, p = 0.084) in patients with CC or CT genotype than in patients with TT genotype. Uncommon TT genotype of ERCC1 19007 T>C polymorphism could predict poor response and shortening of progression free survival in NSCLC patients treated with platinum-based I-line chemotherapy. The analysis of this polymorphism may serve as a promising tool in the qualification of advanced NSCLC patients for appropriate chemotherapy.
Abstract
higher (HR = 0.503, 95% CI: 0.129–1.137, p = 0.084) in patients with CC or CT genotype than in patients with TT genotype. Uncommon TT genotype of ERCC1 19007 T>C polymorphism could predict poor response and shortening of progression free survival in NSCLC patients treated with platinum-based I-line chemotherapy. The analysis of this polymorphism may serve as a promising tool in the qualification of advanced NSCLC patients for appropriate chemotherapy.
Keywords
ERCC1; single-nucleotide polymorphism; non-small cell lung cancer staging; platinum-based chemotherapy
Title
Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer — a pilot study
Journal
Folia Histochemica et Cytobiologica
Issue
Article type
Original paper
Pages
80-86
Published online
2012-04-25
Page views
2423
Article views/downloads
2775
DOI
10.5603/FHC.2012.0011
Bibliographic record
Folia Histochem Cytobiol 2012;50(1):80-86.
Keywords
ERCC1
single-nucleotide polymorphism
non-small cell lung cancer staging
platinum-based chemotherapy
Authors
Paweł Krawczyk
Kamila Wojas-Krawczyk
Radosław Mlak
Tomasz Kucharczyk
Beata Biernacka
Janusz Milanowski